Risk of Venous Thromboembolism in Cancer Patients Treated with Epoetins or Blood Transfusions

被引：0
|
作者：
Douros, Antonios [1 ,2 ]
Jobski, Kathrin [1 ]
Kollhorst, Bianca [3 ]
Schink, Tania [1 ]
Garbe, Edeltraut [1 ]
机构：
[1] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Clin Epidemiol, Bremen, Germany
[2] Charite, Clin Pharmacol & Toxicol, D-13353 Berlin, Germany
[3] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Biometry & Data Management, Bremen, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
544
引用
收藏
页码：311 / 311
页数：1
相关论文
共 50 条
  • [31] Risk of recurrence of venous thromboembolism in patients with gynaecological cancer
    Marchocki, Z.
    Abu Saadeh, F.
    Gleeson, N.
    Norris, L.
    THROMBOSIS RESEARCH, 2017, 151 : S133 - S133
  • [32] Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis
    Pedersen, A. B.
    Vandenbroucke, J.
    Horvath-Puho, E.
    Sorensen, H. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (12) : 2325 - 2332
  • [33] Risk Factors Associated with Venous Thromboembolism in Cancer Patients
    Lee, Su Jung
    Kim, Nam Cho
    ASIAN ONCOLOGY NURSING, 2015, 15 (03) : 171 - 177
  • [34] Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Kobayashi, Kokoro
    Shinozaki, Eiji
    Matsusaka, Satoshi
    Chin, Keisho
    Kuboki, Yasutoshi
    Ichimura, Takashi
    Ozaka, Masato
    Ogura, Mariko
    Fujiwara, Yoshimasa
    Matsueda, Kiyoshi
    Konishi, Fumio
    Hatake, Kiyohiko
    MEDICAL ONCOLOGY, 2010, 27 (03) : 807 - 814
  • [35] Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
    Mitsukuni Suenaga
    Nobuyuki Mizunuma
    Kokoro Kobayashi
    Eiji Shinozaki
    Satoshi Matsusaka
    Keisho Chin
    Yasutoshi Kuboki
    Takashi Ichimura
    Masato Ozaka
    Mariko Ogura
    Yoshimasa Fujiwara
    Kiyoshi Matsueda
    Fumio Konishi
    Kiyohiko Hatake
    Medical Oncology, 2010, 27 : 807 - 814
  • [36] Venous thromboembolism and cancer risk
    Per Sandén
    Peter J. Svensson
    Anders Själander
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 68 - 73
  • [37] Venous thromboembolism and cancer risk
    Sanden, Per
    Svensson, Peter J.
    Sjalander, Anders
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 68 - 73
  • [38] Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)
    Soini, B.
    Caffo, O.
    Ferro, A.
    Ambrosini, G.
    Murgia, V.
    Valduga, F.
    Caldara, A.
    Eccher, C.
    Tumulo, S.
    Galligioni, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Risk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis.
    Seng, Sonia Maria
    Liu, Ziyue
    Chiu, Sophia
    Proverbs-Singh, Tracey
    Sonpavde, Guru
    Choueiri, Toni K.
    Tsao, Che-Kai
    Yu, Menggang
    Hahn, Noah M.
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors
    Icht, Oded
    Darzi, Naama
    Shimony, Shai
    Jacobi, Oded
    Reinhorn, Daniel
    Landman, Yosef
    Mutai, Raz
    Averbuch, Itamar
    Shochat, Tzippy
    Spectre, Galia
    Raanani, Pia
    Rotem, Ofer
    Dudnik, Elizabeth
    Peled, Nir
    Zer, Alona
    Leader, Avi
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1250 - 1258
12345